Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Musculoskeletal
Disease Category: Knee Replacement
Trial Information
Study of MK0663/Etoricoxib in Postorthopedic Knee Replacement Surgery Pain
A Phase III Randomized, Double-Blind, Placebo and Active Comparator-Controlled, Multiple Dose, Clinical Trial to Study the Safety and Efficacy of MK-0663/Etorcixib and Ibuprofen in the Treatment of Postorthopedic Knee Replacement Surgery Pain
Patient Inclusion Criteria:
- Patients is 18 years of age or older
- Patient is in generally good health and is scheduled to have a total knee replacement
Patient Exclusion Criteria:
- Patient is allergic, intolerant to, or has a history of a significant clinical or laboratory adverse experience associated with etoricoxib or other COX-2 inhibitors/NSAIDs, ibuprofen, morphine, or oxycodone, or has hypersensitivity to aspirin, or other NSAIDs
- Patient has uncontrolled hypertension
- Patient is currently a user of any illicit drugs, or has a history of drug or alcohol abuse within the past 5 years
Kelly Colucci, Manager, Grants and Contracts
Atlantic Health System
475 South Street
Morristown, NJ 07962
Phone: 973-660-3139
EMail: kelly.colucci@atlantichealth.org
View Google Map
Research Center Information: Atlantic Health System
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
